by Vora Corporate Finance | Mar 9, 2024 | Insights, Merger & Acquisitions
Transaction: Eris Lifesciences Ltd., a leading Indian branded formulations company, today announced the expansion of its Sterile Injectable footprint through the acquisition of 51% equity stake in Swiss Parenterals Ltd. for a consideration of Rs 637.50 Crore. This...
